Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060504

CFO & Executive Vice President sold 6,738 shares at an average $82.00 ($552,524)

From the SEC's structured data for this filing

Trades in this filing

Dier Mardi · CFO & Executive Vice President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-12 Sale : show line 1 in the form −3,477 $82.79 $287,861 42,023 D
2021-10-14 Sale : show line 2 in the form −3,261 $81.16 $264,663 38,762 D
Open-market sales · 6,738 sh · avg $82.00 · $552,524
Loading xslF345X03/doc4.xml…